Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Business
Mark Banham

GSK buys US-based cancer specialist Sierra Oncology for $1.9 billion

Pharma giant GSK has bought cancer specialist Sierra Oncology

(Picture: PA)

Pharmaceutical giant GlaxoSmithKline (GSK) has bought California-based cancer treatment company Sierra Oncology for $1.9 billion (£1.5 billion).

Sierra is in the process of submitting its momelotinib drug for regulatory approval later in the year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.